https://www.selleckchem.com/products/azd8186.html
Background Expert opinion guidelines and limited data from clinical trials recommend adjustment to bolus insulin doses based on continuous glucose monitor (CGM) trend data, yet minimal evidence exists to support this approach. We performed a clinical evaluation of a novel CGM-informed bolus calculator (CIBC) with automatic insulin bolus dose adjustment based on CGM trend used with sensor-augmented pump therapy. Materials and Methods In this multicenter, outpatient study, participants 6-70 years of age with type 1 diabetes (T1D) used the
Aimer
Commentaire
Partagez
